Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers' Opdivo fails key lung cancer study, stocks ricochet
Bristol-Myers' Opdivo fails key lung cancer study, stocks ricochet
Bristol-Myers' Opdivo fails key lung cancer study, stocks ricochet
Submitted by
admin
on August 5, 2016 - 11:37am
Source:
BioPharma Dive
News Tags:
Bristol-Myers Squibb
Opdivo
Merck Keytruda
non-small cell lung cancer
PD-L1
Headline:
Bristol-Myers' Opdivo fails key lung cancer study, stocks ricochet
Do Not Allow Advertisers to Use My Personal information
